PAXIL CR Bioequivalence Study

NCT00749359 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
166
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline